{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Integrated Transitions of Care for Patients with Rare Pulmonary Disease

Activity Steps

1 Activity
2 Take Test 3Certificate

Purpose of Activity

To provide information for case managers about the development of transitions-of-care (TOC) pathways for patients with pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF).

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Outline the development of the collaborative interdisciplinary TOC pathways and key foundations of knowledge about PAH and IPF.
  2. Recognize the epidemiology, signs and symptoms, and care gaps about PAH and IPF.
  3. Summarize the medication management, barriers to TOC, and role of case managers in transition planning for patients with PAH and IPF.

Disclosures

Funding support: The transitions of care pathways described in this article were developed for continuing education programs supported through independent education grants from Gilead Sciences, Inc. and Genentech, which were awarded to PRIME Education, Inc. Gilead Sciences, Inc. and Genentech had no role in the programs' design or execution. Funding was provided for the development of the pathways only. No funding was associated with development of this CE activity.

This continuing education activity is not a co-provided activity; it is provided solely by Lippincott Williams & Wilkins.

Disclosures: Cheri Lattimer, RN, BSN, has disclosed past financial relationships with Janssen Pharmaceuticals, Inc. and Boehringer-Ingelheim. This article has been reviewed, and all potential or actual conflicts have been resolved.

The other authors and the planners have disclosed that they have no significant relationship with or financial interest in any commercial companies that pertain to this educational activity.

Price: $12.95

Credits:

  • ANCC 1.0 CH
  • CCMC 1.0 CH
  • NAHQ 1.0 CEH
  • DC - BON 1.0 CH
  • KY-BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.

This Continuing Education (CE) activity is provided by Lippincott Williams & Wilkins and has been preapproved by the Commission for Case Manager Certification (CCMC) for 1.0 CE contact hours.

This continuing education (CE) activity is provided by Lippincott Williams & Wilkins and has been approved by the National Association for Healthcare Quality (NAHQ) for 1.0 CPHQ CE Hours. CPHQ CE Hours are based on a 60-minute hour. This CE is approved for meeting requirements for certification renewal.







Planner
Test Code: PCM0317A
Published: Mar/Apr 2017
Expires: 12/31/2026
Sources: Professional Case Management
Required Passing Score: 14/19 (73%)
Authors: Kathleen Moreo, BSN, BHSA, RN-BC, CCM, CDMS; Cheri Lattimer, BSN, RN; James E. Lett, MD, CMD; Cherilyn L. Heggen-Peay, PhD; Laura Simone, PhD
Categories: Case Management , Respiratory
Specialties: Pulmonary
Topics: Case Management Roles , Discharge Planning , Pulmonary Fibrosis , Pulmonary Hypertension , Transitions of Care